Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study evaluating alvelestat versus placebo for alpha-1 antitrypsin deficiency-related lung disease, including its eligibility criteria, locations, and measured outcomes. The study is no longer recruiting participants.
    Difference
    59%
    Check dated 2026-11-11T01:50:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:08:49.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. The site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:19:04.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0; the study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:29.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record. This prevents users from accessing the trial's details, including its title, design, eligibility criteria, locations, and contact information.
    Difference
    18%
    Check dated 2026-09-23T00:12:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated to v3.7.0, indicating a backend update to the page. The study content and displayed information remain unchanged.
    Difference
    0.0%
    Check dated 2026-09-15T23:37:31.000Z thumbnail image

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.